Selection of Filovirus Isolates for Vaccine Development Programs.

Wolfe DN, Sabourin CL, Merchlinsky MJ, Florence WC, Wolfraim LA, Taylor KL, Ward LA

Open source

DOI
10.3390/vaccines9091045
Published
2021 Sep 19
Container
Vaccines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/vaccines9091045,
  title = {Selection of Filovirus Isolates for Vaccine Development Programs.},
  author = {Wolfe DN and Sabourin CL and Merchlinsky MJ and Florence WC and Wolfraim LA and Taylor KL and Ward LA},
  year = {2021},
  journal = {Vaccines},
  doi = {10.3390/vaccines9091045},
  url = {https://doi.org/10.3390/vaccines9091045}
}

RIS

TY  - JOUR
TI  - Selection of Filovirus Isolates for Vaccine Development Programs.
AU  - Wolfe DN
AU  - Sabourin CL
AU  - Merchlinsky MJ
AU  - Florence WC
AU  - Wolfraim LA
AU  - Taylor KL
AU  - Ward LA
PY  - 2021
JO  - Vaccines
DO  - 10.3390/vaccines9091045
UR  - https://doi.org/10.3390/vaccines9091045
ER  - 

APA

DN, W., CL, S., MJ, M., WC, F., LA, W., KL, T., & LA, W. (2021). Selection of Filovirus Isolates for Vaccine Development Programs.. Vaccines. https://doi.org/10.3390/vaccines9091045

Source records